OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 06, 2018
On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.
April 05, 2018
The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.
The contract service provider will invest in a laboratory expansion at its site located in Tredegar, Wales, UK.
April 02, 2018
Particle engineering using jet milling or spray drying can be used to obtain appropriate particle characteristics for inhalation drug products.
Access to multiple analytical techniques is essential for fully characterizing complex protein formulations.
CMOs/CDMOs that are easy to work with, have demonstrated performance track records, and plan for the future are preferred.
Industry analyst Jim Miller will provide insight into the past, present, and future of the contract services market at the CPhI North America conference on Wednesday, April 25, 2018 in Philadelphia, PA.
Certificates of analysis can be used to monitor the reliability of products and their suppliers, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.